Immunotherapy, a form of cancer treatment that often requires expensive hospital-based injections, may one day be available ...
According to the latest research report published by MarkNtel Advisors, the Global Plasma Fractionation Market is projected ...
Pregnant Sophie Kasaei has said she is in a 'living nightmare' as boyfriend Jordan Brook remains in hospital battling viral ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that British Columbia, ...
Nivolumab plus AVD is now FDA-approved for previously untreated Stage III or IV classical Hodgkin lymphoma in patients aged 12 years and older.
FDA encourages the Company to submit comprehensive data from sunRIZE and the ongoing open-label extension to inform next steps for the programREDWOOD CITY, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- ...
Every minute, nearly 500 antibiotic prescriptions are written in the U.S. Many of these drugs succeed, but more are being ...
Chugai receives Japanese approval for Lunsumio & Polivy combo therapy for additional indication of relapsed or refractory large B-cell lymphoma: Tokyo Tuesday, March 24, 2026, 11: ...
Meg Flippin, Benzinga Staff Writer CHICAGO, IL AND FORT WORTH, TX / ACCESS Newswire / March 24, 2026 / Actuate Therapeutics, ...
An Essex woman who contracted bacterial meningitis twice “didn’t know if I was going to make it or not, or if I was going to ...
Scientists have proven that a wildflower steeped in folklore for its medicinal powers has genuine healing qualities—and the ...
On 18 March, Eisai presented four-year data from its OLE period of its Phase III CLARITY-AD trial of Leqembi to treat early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results